Dr. Brian Hill is a medical oncologist from Cleveland,Ohio and he works at several hospitals in the area, such as Cleveland Clinic. He did his Medical Schooling from University of Chicago Pritzker School of Medicine and Residency in Internal Medicine from University of Chicago. The doctor is certified in Internal Medicine, Hematology & Medical Oncology from American Board of Internal Medicine and has an experience of more than 19 years.
University of Chicago Pritzker School of Medicine
University of Chicago
Cleveland Clinic Foundation
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib.
Winter, A. M.,Landsburg, D. J.,Mato, A. R.,Isaac, K.,Hernandez-Ilizaliturri, F. J.,Reddy, N.,Smith, S.,Shadman, M.,Smith, M. R.,Caimi, P.,Jagadeesh, D.,Hill, B. T.; Blood. 2017 Aug 11.See more >>
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Robak T, Hellmann A, Kloczko J, Loscertales J, Lech-Maranda E, Pagel JM, Mato A, Byrd JC, Awan FT, Hebart H, Garcia-Marco JA, Hill BT, Hallek M, Eisenfeld AJ, Stromatt...; Br. J. Haematol.. 2016-12-15.See more >>
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Kharfan-Dabaja MA, Kumar A, Hamadani M, Stilgenbauer S, Ghia P, Anasetti C, Dreger P, Montserrat E, Perales M, Alyea EP, Awan FT, Ayala E, Barrientos JC, Brown JR, Cas...; Biol. Blood Marrow Transplant.. 2016-12-01.See more >>